Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAlzamend Neuro, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$0.29 | -$0.29 | -$0.29 |
| Q2 2025 | 1 | -$0.45 | -$0.45 | -$0.45 |
| Q3 2025 | 1 | -$0.44 | -$0.44 | -$0.44 |
| Q4 2025 | 1 | -$0.43 | -$0.43 | -$0.43 |
| Q1 2026 | 1 | -$0.42 | -$0.42 | -$0.42 |
| Q2 2026 | 1 | -$0.42 | -$0.42 | -$0.42 |
Alzamend Neuro, Inc. Earnings Date And Information
Alzamend Neuro, Inc. last posted its earnings results on Wednesday, December 11th, 2024. The company reported $-0.4 earnings per share for the quarter, topping analysts' consensus estimates of $-2.38 by $1.98. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Alzamend Neuro, Inc. has generated $-15 earnings per share over the last year ($-14.7 diluted earnings per share) and currently has a price-to-earnings ratio of -0.72. Alzamend Neuro, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Sunday, March 23rd, 2025 based on prior year's report dates.
Alzamend Neuro, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 12/11/2024 | Q2 2025 | -$2.38 | -$0.40 | 1.98 | $0 | $0 |
| 09/11/2024 | Q1 2025 | -$2.38 | -$1.25 | 1.13 | $0 | $0 |
| 07/30/2024 | Q4 2024 | -$2.75 | -$1.24 | 1.51 | N/A | $76,110 |
| 03/25/2024 | Q3 2024 | -$0.32 | -$3.78 | -3.46 | N/A | $0 |
| 12/15/2023 | Q2 2024 | N/A | -$4.43 | N/A | N/A | $0 |
| 09/13/2023 | Q1 2024 | -$0.67 | -$5.38 | -4.71 | N/A | $0 |
| 07/27/2023 | Q4 2023 | -$3.38 | -$5.12 | -1.74 | N/A | $0 |
| 03/15/2023 | Q3 2023 | -$0.04 | -$8.28 | -8.24 | N/A | $0 |
| 12/12/2022 | Q2 2023 | -$0.02 | -$4.80 | -4.78 | N/A | $0 |
| 09/13/2022 | Q1 2023 | -$0.07 | -$4.68 | -4.61 | N/A | $0 |
| 07/19/2022 | Q4 2022 | -$0.03 | -$6.60 | -6.57 | N/A | $0 |
| 03/15/2022 | Q3 2022 | -$0.02 | -$4.10 | -4.08 | N/A | $0 |
| 12/13/2021 | Q2 2022 | -$0.03 | -$5.78 | -5.76 | N/A | $0 |
| 09/13/2021 | Q1 2022 | N/A | -$4.12 | N/A | N/A | $0 |
| 07/29/2021 | Q4 2021 | N/A | -$2.55 | N/A | N/A | $0 |
| 01/30/2021 | Q3 2021 | N/A | -$2.33 | N/A | N/A | $0 |
| 10/30/2020 | Q2 2021 | N/A | -$2.82 | N/A | N/A | $0 |
| 07/30/2020 | Q1 2021 | N/A | -$2.74 | N/A | N/A | $0 |
| 04/29/2020 | Q4 2020 | N/A | -$2.62 | N/A | N/A | $0 |
| 01/30/2020 | Q3 2020 | N/A | -$2.67 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Alzamend Neuro, Inc. Earnings: FAQ's
Alzamend Neuro, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Sunday, March 23rd, 2025 based offlast year's report dates.
In the previous quarter, Alzamend Neuro, Inc. (:ALZN) reported $-0.4 earnings per share (EPS) to beat the analysts' consensus estimate of $-2.38 by $1.98.
The conference call for Alzamend Neuro, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Alzamend Neuro, Inc.'s latest earnings report can be read online.
Alzamend Neuro, Inc. (:ALZN) has a recorded net income of $-9,947,746.Alzamend Neuro, Inc. has generated $-14.72 earnings per share over the last four quarters.
Alzamend Neuro, Inc. (:ALZN) has a price-to-earnings ratio of -0.72 and price/earnings-to-growth ratio is -0.02.